NIH-CSR <script type="text/javascript"> var wmNotice = "UNT Web Archive - External links, forms, and search boxes may not function within this collection. Url: http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescription/HOPIRG/NAME.htm time: 14:32:15 Sep 20, 2008"; var wmHideNotice = "hide"; var contextRoot = "https://webarchive.library.unt.edu/eot2008/"; </script> <script type="text/javascript" src="https://webarchive.library.unt.edu/eot2008/js/disclaim.js"></script> <span id="Postingname3_PostingDisplayName">Neurological, Aging and Musculoskeletal Epidemiology [NAME]</span> (HOPIRG)

[NAME Roster]

The Neurological, Aging and Musculoskeletal Epidemiology [NAME] Study Section reviews applications on epidemiologic research in neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis.

Specific areas covered by NAME:

The general characteristics of the distribution of the neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis in human populations in relation to time, place, and personal characteristics.
Elucidation of the determinants of the neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis by assembling groups of individuals to determine systematically whether the risk of disease/condition is different for individuals who are exposed or not exposed to specific factors (or combinations of factors) of interest. These may be either risk or protective factors.
Development and improvement of research designs and methodologies addressing epidemiologic questions in the neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis.

NAME has the following shared interests within the HOP IRG:

With Biostatistical Methods and Research Design [BMRD]: BMRD also reviews applications dealing with epidemiologic methods and research design. If the primary thrust of the application is to develop new statistical methodologies, the application may be reviewed by BMRD. If the focus is on improving existing methodologies for epidemiologic research, the application may be assigned to NAME.
With Community Influences on Health Behavior [CIHB] and Community-Level Health Promotion [CLHP]:CIHB and CLHP also review applications dealing with neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis. If the primary focus of the proposed study is on neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis, then the application may be reviewed in NAME. But if the application emphasizes community or societal institutions such as school, church, work site, or mass media, the application may be reviewed by CIHB or CLHP, depending upon whether a community-based intervention is involved.
With Nursing Science: Adults and Aging [NSAA] or Nursing Science: Children and Families [NSCF]:The NSAA and NSCF Study Sections also review applications dealing with neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis.When the primary focus is on nursing science, the application may be assigned to NSAA or NSCF, depending upon the age range involved. An application may be assigned to NAME when it is an overall epidemiological study.
With Social Sciences and Population Studies [SSPS]: SSPS also reviews applications dealing with the incidence and prevalence of neurological disorders (including the epidemiology of Alzheimer's Disease, dementias, stroke, Parkinson's Disease, and epilepsy), conditions related to human aging (including, falls and fractures, functional status, frailty, quality of life, health care use, and other areas as they relate to populations of older persons), and musculoskeletal disorders such as arthritis, osteoarthritis and osteoporosis. Applications that rely primarily upon epidemiologic methods may be reviewed by NAME. Applications relating levels of morbidity and mortality to demographic or socioenvironmental factors or the effects of public policy on morbidity or mortality levels may be reviewed by SSPS.

NAME has the following shared interests outside the HOP IRG:

With the Genes, Genomes and Genetics [GGG] IRG: NAME has extensive shared interests with GGG for applications involving genetic epidemiology. The level of genetic technology to epidemiology needs to be considered in assignment decisions between these two study sections. More technical applications could be reviewed by GGG. Studies with substantial laboratory components are appropriate for NAME when the primary thrust is epidemiologic and laboratory data are to be collected by methods that are largely already developed. Genetic linkage studies could go to either the GGG IRG or to NAME. Molecular epidemiology studies alone or in combination with linkage studies could be reviewed in NAME. Genetic studies using animals could be assigned to GGG or another IRG, depending upon the primary thrust of the application.
With the Biology and Development of Aging [BDA] IRG: Applications with a primary focus on the physiologic or biological processes of aging could be reviewed by BDA. However, applications with a primary approach on behavioral or social antecedents or outcomes and using epidemiologic approaches to dementia, mood disorders, behavioral prevention and management of physical diseases, and cognitive impairments could be reviewed by NAME.
With the Risk, Prevention and Health Behavior [RPHB] IRG: The RPHB IRG also reviews applications dealing with variations in risk behavior. Epidemiologic studies examining behavior as a risk factor could be referred to NAME. Non-epidemiologic studies with a behavioral intervention component to change health behavior could be referred to RPHB or NAME, depending upon whether the emphasis is upon the individual or the community level context.
With the Infectious Diseases and Microbiology [IDM] IRG: Studies that have substantial laboratory components are appropriate for NAME (depending upon the disease/condition being studied) when the primary thrust is epidemiologic and laboratory data are to be collected by methods that are largely already developed. When epidemiology is a minor component or when the epidemiology focuses on the non-human disease vector or the genetic identity of the disease subspecies, the application may be reviewed in the IDM IRG.
With the Musculoskeletal, Oral and Skin Sciences [MOSS] IRG: The MOSS IRG also reviews applications directed toward the prevention and treatment of oral and dental health, osteoporosis and other bone diseases, arthritis and dermatological conditions. Clinical trials focused on interventions in oral or dental health, osteoporosis and other bone diseases, arthritis and dermatological conditions may be reviewed in MOSS. Studies of these conditions may be referred to NAME when the primary thrust is epidemiologic and laboratory data are to be collected by methods that are largely already developed. Applications on the diseases or functional consequences of behaviors could be assigned to MOSS. Animal studies may be reviewed in the MOSS IRG.
With the Brain Disorders and Clinical Neuroscience [BDCN] IRG: Clinical trials could be reviewed within BDCN. Epidemiologic studies of various neurological disorders including Alzheimer’s disease, Parkinson’s disease, stroke and epilepsy may be reviewed in NAME. Non-epidemiologic studies of these disorders, including studies in animals, could be reviewed within the BDCN IRG.